Search research articles
Contact Us
Filters
Showing results (91-100 of 157) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Miguel A Villalona-Calero, Paul Ritch, Jose A Figueroa, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy
Andrew C Johns, Mike Yang, Lai Wei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer
Eric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)
|
October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
Eric D Miller, James L Fisher, Karl E Haglund, et al.
Cancer
|
April 19, 2016
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer
Lia M Halasz, Hajime Uno, Melissa Hughes, et al.
Plos One
|
June 19, 2008
HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells
Guolin Chai, Lian Li, Wen Zhou, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
Elaine T Lam, Jessie L-S Au, Gregory A Otterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871
Lionel D Lewis, Antonius A Miller, Gary L Rosner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer
Ludmila Katherine Martin, John Grecula, Guang Jia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLC
D Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 157) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Miguel A Villalona-Calero, Paul Ritch, Jose A Figueroa, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy
Andrew C Johns, Mike Yang, Lai Wei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer
Eric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)
|
October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
Eric D Miller, James L Fisher, Karl E Haglund, et al.
Cancer
|
April 19, 2016
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer
Lia M Halasz, Hajime Uno, Melissa Hughes, et al.
Plos One
|
June 19, 2008
HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells
Guolin Chai, Lian Li, Wen Zhou, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
Elaine T Lam, Jessie L-S Au, Gregory A Otterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871
Lionel D Lewis, Antonius A Miller, Gary L Rosner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer
Ludmila Katherine Martin, John Grecula, Guang Jia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLC
D Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
Page
of 16